Evaluation and Management of Vaginal Itching and Bleeding in a 33-Year-Old Female
This patient requires immediate office-based diagnostic testing including vaginal pH, wet mount microscopy with KOH preparation, and consideration of yeast culture to differentiate between vulvovaginal candidiasis (most likely given the itching), bacterial vaginosis, trichomoniasis, or non-infectious causes before initiating treatment.
Diagnostic Approach
The combination of vaginal itching and bleeding requires systematic evaluation, as itching is the most specific symptom for vulvovaginal candidiasis (VVC), while bleeding suggests additional pathology 1.
Essential Office Testing
Perform these tests during the initial visit 2:
- Vaginal pH measurement: Normal pH (<4.5) suggests VVC; elevated pH (>4.5) indicates bacterial vaginosis or trichomoniasis
- Saline microscopy: Look for motile trichomonads, clue cells (bacterial vaginosis), or inflammatory cells
- 10% KOH microscopy: Identifies yeast hyphae or budding yeast (present in only ~50% of VVC cases) 1
- Whiff test: Fishy odor with KOH application indicates bacterial vaginosis
- Yeast culture with speciation: Critical when microscopy is negative but symptoms suggest VVC, or for recurrent cases 3
Key Clinical Distinctions
For VVC (most likely given itching) 1, 2:
- White, thick, curd-like discharge
- Vulvar erythema and swelling
- Absence of odor (LR 2.9 for candidiasis) 4
- Dyspareunia or dysuria may be present
For bacterial vaginosis 2:
- Thin, homogenous gray-white discharge
- Fishy odor (absence makes BV unlikely, LR 0.07) 4
- Minimal inflammation
For trichomoniasis 2:
- Green or yellow frothy discharge
- Cervical petechiae ("strawberry cervix")
- Must test for other STIs and treat partners
Treatment Algorithm
If VVC is Confirmed
First-line treatment options 1:
Oral therapy (most convenient):
- Fluconazole 150 mg single dose
Intravaginal therapy (over-the-counter):
- Miconazole 1200 mg suppository (single dose)
- Clotrimazole 2% cream 5g daily × 3 days
- Tioconazole 6.5% ointment 5g single application
Prescription intravaginal:
- Terconazole 0.8% cream 5g daily × 3 days
If Bacterial Vaginosis is Confirmed
- Metronidazole 500 mg orally twice daily × 7 days, OR
- Metronidazole gel 0.75% intravaginally daily × 5 days, OR
- Clindamycin cream 2% intravaginally at bedtime × 7 days 2
If Trichomoniasis is Confirmed
- Metronidazole 500 mg orally twice daily × 7 days (preferred over single-dose for this STI) 5, 2
- Test for other STIs
- Treat sexual partners
- Test for reinfection in 3 months
Critical Pitfalls to Avoid
Do not treat empirically based on symptoms alone 4. Less than half of patients clinically diagnosed with VVC actually have it when objective testing is performed 1. The poor sensitivity of clinical diagnosis and microscopy (which misses ~50% of VVC cases) means culture or molecular testing is frequently necessary 1.
Address the bleeding component separately. While VVC can cause minor bleeding from inflammation, significant bleeding in a 33-year-old requires evaluation for 6:
- Cervical pathology (perform Pap smear if due)
- Anovulatory bleeding
- Structural lesions (fibroids, polyps)
- Sexually transmitted infections causing cervicitis
For non-albicans Candida species (particularly C. glabrata), if identified on culture and standard azoles fail 3, 5:
- Vaginal boric acid 600 mg capsules intravaginally daily × 14 days is the most cost-effective alternative
If initial treatment fails 5:
- Reconsider the diagnosis
- Obtain yeast culture with speciation
- Consider non-infectious causes: desquamative inflammatory vaginitis, genitourinary syndrome of menopause, vulvodynia, or vulvar dermatoses 7
When Molecular Testing is Superior
Molecular diagnostic tests (NAAT) are likely superior to office microscopy for most clinicians, particularly when microscopy is negative but symptoms persist 5. However, culture remains the gold standard and provides speciation data crucial for treatment-resistant cases 1.